Colaris in Stuart

Colaris – A Test for Hereditary nonpolyposis colorectal Cancer (Lynch syndrome)

How is the COLARIS test performed?
Blood is drawn from the patient (only a small amount is needed) and remited to the Genetic laboratory for DNA sequencing analysis of the APC and MYH genes. Moreover, COLARIS AP can detect large relocation in the APC gene that will not be identified by gene sequencing.


Benefits of COLARIS® Testing
The risk of cancer will be considerably decreased by the development of each patient unique medical organization plan as from COLARIS test’s results analysis. COLARIS test will provide you with:

  Guidance to patients and family members on the principal causes of cancer in their family.
Maximum patient care and increasing clinical efficiency through Improved examination and other interventions specifically to persons with a Lynch syndrome or MYH associated polyposis mutation(s).
  Reduced medical costs through prevention, earlier diagnosis and treatment of cancer.
  Acknowledged of family members who do not test positive for the mutation(s) identified in the family, in order to avoid unnecessary interventions
  ©  Copyright 2019 ICRHW   privacy policy Ph: (772)-539-9556 or (772)-539-9119    fax: 772 539-0175